Barnes Katherine S, Singh Sumit, Barkley Ariana, Lepard Jacob, Hopson Betsy, Cawyer Chase R, Blount Jeffrey P, Rocque Brandon G
Department of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Department of Radiology, University of Texas Southwestern, Dallas, Texas, USA.
Childs Nerv Syst. 2022 May;38(5):985-990. doi: 10.1007/s00381-022-05469-9. Epub 2022 Feb 18.
Ultrasound is the primary method for prenatal identification of myelomeningocele and is critical to prognostication and treatment planning. No study has considered the degree of inaccuracy of prenatal US lesion level estimates and anatomic lesion level on postnatal imaging using the weighted kappa coefficient (κw), nor the impact of maternal BMI on agreement. We examined the accuracy of prenatal ultrasound lesion level estimation in a cohort of patients with myelomeningocele using κw and determined whether BMI influenced accuracy.
The study is a retrospective review including patients born 2011-2019 who had prenatal imaging and primary myelomeningocele closure at a single institution. Lesion levels from prenatal ultrasound and postnatal imaging studies were analyzed for agreement at exact level, within 1 level, and within 2 levels using κw. Maternal BMI was examined for correlation with accuracy.
Fifty-seven patients met inclusion criteria. Mean BMI was 31.2. There was no association between maternal BMI and agreement at any level. Lesion level on prenatal ultrasound agreed with postnatal imaging to the exact level in 13 (22.8%) cases, within 1 level in 38 (66.7%) cases, and within 2 levels in 50 (87.7%) cases. Weighted kappa showed moderate agreement at exact level (κ = 0.494) and substantial agreement within 1 (κ = 0.761) and 2 levels (κ = 0.902).
Weighted kappa adds confidence for clinical decision making by accounting for accuracy. Prenatal ultrasound is a reliable and accurate method of determining lesion level with near-perfect agreement to postnatal imaging within 2 spinal levels. Maternal BMI may not influence lesion level determination after initial diagnosis.
超声是产前识别脊髓脊膜膨出的主要方法,对预后评估和治疗规划至关重要。尚无研究使用加权kappa系数(κw)考量产前超声对病变水平估计的不准确程度与产后影像学检查中解剖学病变水平之间的差异,也未考虑孕妇体重指数(BMI)对一致性的影响。我们使用κw系数检查了一组脊髓脊膜膨出患者产前超声对病变水平估计的准确性,并确定BMI是否会影响准确性。
本研究为一项回顾性分析,纳入了2011年至2019年在单一机构进行产前影像学检查并接受原发性脊髓脊膜膨出闭合手术的患者。使用κw系数分析产前超声和产后影像学检查的病变水平在精确层面、相差1个层面和相差2个层面时的一致性。研究孕妇BMI与准确性之间的相关性。
57例患者符合纳入标准。平均BMI为31.2。孕妇BMI与任何层面的一致性均无关联。产前超声检查的病变水平与产后影像学检查结果在精确层面一致的有13例(22.8%),相差1个层面的有38例(66.7%),相差2个层面的有50例(87.7%)。加权kappa系数显示在精确层面为中度一致性(κ = 0.494),相差1个层面时为高度一致性(κ = 0.761),相差2个层面时为几乎完全一致性(κ = 0.902)。
加权kappa系数通过考量准确性为临床决策增添了信心。产前超声是确定病变水平的可靠且准确的方法,与产后影像学检查在相差2个脊髓节段内几乎完全一致。初次诊断后,孕妇BMI可能不会影响病变水平的确定。